The results showed that Limonin significantly reduced the accumulation of lipid droplets in the liver and down-regulated the levels of lipogenic transcription factors FASN and SREBP1 in NAFLD. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.